Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

NCT00539591 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.

NCT NCT00539591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00539591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
Lead sponsor
St. Jude Children's Research Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 9, 2008
Completion date
May 31, 2031
Enrollment
29 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma